• Thursday, September 30, 2021 @ 12:00 am

Santersus AG announces the successful completion of their first in human clinical trials relating to Sepsis and COVID-19.

  • First trial started in Feb 2021 in Sepsis/COVID-19
  • Recruitment completed in September 2021 with 10 patients
  • Interim analysis showed safe, easy to apply, confirmed the reduction in NETs with a strong temporal association with clinical improvement

You may also be interested in